Your Article Summary
See Latest ArticlesDigestive adverse effects due to sodium polystyrene sulfonate (Kayexalate) in dialysis patients
Néphrologie & Thérapeutique , 06/09/09
Montagnac R et al. - Administered to reduce hyperkaliema in patients with chronic renal failure, sodium polystyrene sulfonate (Kayexalate) can cause digestive complications. The most severe complication could be the intestinal necrosis or perforation. In the present report, the authors evoke these complications and illustrate them with some pictures from personal observations.
Today in Dialysis...keeping you current
Receive free subspecialty "5-minute updates" via email
Managing diabetes in hemodialysis patients: Observations and recommendations
Cleveland Clinic Journal of Medicine, 11/04/09
Correlation between parameters at initiation of renal replacement therapy and outcome in patients with acute kidney injury
Critical Care, 11/11/09
Increasing dialysate flow rate increases dialyzer urea clearance and dialysis efficiency: An in vivo study
Saudi Journal of Kidney Diseases and Transplantation, 11/02/09
Today in Fluids and Electrolytes...keeping you current
Receive free subspecialty "5-minute updates" via email
Systematic Review: Sodium Bicarbonate Treatment Regimens for the Prevention of Contrast-Induced Nephropathy
Annals of Internal Medicine, 11/03/09
New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children
Pediatric Nephrology, 11/11/09
Does Concomitant Administration of Sevelamer and Calcium Carbonate Modify the Control of Phosphatemia
Therapeutic Apheresis and Dialysis, 11/04/09